Definition of an efficient synthetic poly(A) site. by Levitt, N, Briggs, D, Gil, A, Proudfoot, N

A pause site for RNA polymerase II is associated with termination of transcription. by Enriquez-Harris, P, Levitt, N, Briggs, D, Proudfoot, N

Point-of-care HbA1c testing in an urban primary care diabetes clinic in South Africa – a mixed methods feasibility study by Hirst, J, Bobrow, K, Farmer, A, Morgan, J, Levitt, N

The SMS-text Adherence support (StAR) study - Hardware and software infrastructure by Springer, D, Bobrow, K, Levitt, N, Farmer, A, Tarassenko, L

The diagnostic accuracy of HbA1c, compared to the oral glucose tolerance test, for screening for type 2 diabetes mellitus in Africa—a systematic review and meta-analysis by Chivese, T, Hirst, J, Matizanadzo, JT, Custodio, M, Farmer, A, Norris, S, Levitt, N

Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa by Leon, N, Namadingo, H, Bobrow, K, Cooper, S, Crampin, A, Pauly, B, Levitt, N, Farmer, A

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population. by Bethel, M, Deedwania, P, Levitt, N, Schmitz, O, Huntsman-Labed, A, Califf, R, Haffner, S, Diem, P

Patient preferences for the integration of mental health counseling and chronic disease care in South Africa by Myers, B, Joska, J, Lund, C, Levitt, N, Butler, C, Naledi, T, Milligan, P, Stein, D, Sorsdahl, K

Efficacy of a text messaging (SMS) based intervention for adults with hypertension: protocol for the StAR (SMS Text-message Adherence suppoRt trial) randomised controlled trial. by Bobrow, K, Brennan, T, Springer, D, Levitt, N, Rayner, B, Namane, M, Yu, L, Tarassenko, L, Farmer, A

Using the Medical Research Council framework for development and evaluation of complex interventions in a low resource setting to develop a theory-based treatment support intervent... by Bobrow, K, Farmer, A, Cishe, N, Nwagi, N, Namane, M, Brennan, T, Springer, D, Tarassenko, L, Levitt, N

Comparing dedicated and designated models of integrating mental health into chronic disease care: study protocol for a cluster randomized controlled trial by Myers, B, Lund, C, Lombard, C, Joska, J, Levitt, N, Butler, C, Cleary, S, Naledi, T, Milligan, P, Stein, D, Sorsdahl, K

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer. by Khan, O, Ranson, M, Michael, M, Olver, I, Levitt, N, Mortimer, P, Watson, A, Margison, G, Midgley, R, Middleton, MR

Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles. by Mehta, S, Hughes, N, Buffa, F, Li, S, Adams, R, Adwani, A, Taylor, N, Levitt, N, Padhani, A, Makris, A, Harris, A

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. by Bethel, M, Chacra, A, Deedwania, P, Fulcher, G, Holman, R, Jenssen, T, Kahn, SE, Levitt, N, McMurray, J, Califf, R, Raptis, SA, Thomas, L, Sun, J, Haffner, S

A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk by Bethel, M, Chacra, A, Deedwania, P, Fulcher, G, Holman, R, Jenssen, T, Kahn, SE, Levitt, N, McMurray, J, Califf, R, Raptis, SA, Thomas, L, Sun, J, Haffner, S

Updated risk factors should be used to predict development of diabetes. by Bethel, M, Hyland, K, Chacra, A, Deedwania, P, Fulcher, G, Holman, R, Jenssen, T, Levitt, N, McMurray, J, Boutati, E, Thomas, L, Sun, J, Haffner, S, NAVIGATOR Study Group

Mobile messaging support versus usual care for people with type 2 diabetes on clycemic control: Protocol for a multicenter randomized controlled trial by Farmer, A, Bobrow, K, Leon, N, Williams, N, Phiri, E, Namadingo, H, Cooper, S, Prince, J, Crampin, A, Besada, D, Daviaud, E, Yu, L, Ngoma, J, Springer, D, Pauly, B, Norris, S, Tarassenko, L, Nyirenda, M, Levitt, N

Mobile messaging support versus usual care for people with type 2 diabetes on glycemic control: protocol for a multicenter randomized controlled trial by Farmer, A, Bobrow, K, Leon, N, Williams, N, Phiri, E, Namadingo, H, Cooper, S, Prince, J, Crampin, A, Besada, D, Daviaud, E, Yu, L-M, Ngoma, J, Springer, D, Pauly, B, Norris, S, Tarassenko, L, Nyirenda, M, Levitt, N

Digital messaging to support control for type 2 diabetes (StAR2D): a multicentre randomised controlled trial by Farmer, A, Bobrow, K, Leon, N, Williams, N, Phiri, E, Namadingo, H, Cooper, S, Prince, J, Crampin, A, Besada, D, Daviaud, E, Yu, L-M, N'goma, J, Springer, D, Pauly, B, Tarassenko, L, Norris, S, Nyirenda, M, Levitt, N